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Abstract		
Introduction:	The	 aim	 of	 the	 study	 is	 to	 determine	 the	 correlation	 between	 carbohydrates,	 fat	
and	protein	intake	with	the	serum	C-Reactive-Protein	level	in	lung	cancer	patients	stage	IIIB	–	IV.	
The	progression	of	lung	cancer	is	influenced	by	immune	system,	genetic	factors	and	inflammatory	
response,	therefore	CRP	can	be	relied	as	one	of	the	parameters	for	predicting	cancer	cell	growth.	
Methods:	 A	 cross	 sectional	 study	was	 conducted	 in	Dharmais	 Cancer	Hospital	 Jakarta.	 Subjects	
were	recruited	by	consecutive	sampling,	49	subjects	with	lung	cancer	stage	IIIB–IV		who	currently	
not	receiving	any	treatment	in	Dharmais	Hospital	participating	in	this	study.		
Results:	The	mean	age	of	subject	was	55.82	+	12.26	years	old	and	63.3%	were	male.	The	median	
value	of	CRP	is	23.82	(0.30–207.29)	mg/L.	The	correlation	between	carbohydrate,	protein	and	fat	
intake	with	 serum	CRP	 level	 (r=0.015	and	p=0.919;	 r=-0.165	and	p=0.257;	 r=0.003	and	p=0.986,	
respectively).		
Conclusion:	This	study	did	not	show	significant	correlation	between	carbohydrate,	protein	and	fat	
intake	with	serum	CRP	level.	In	further	analysis	we	did	found	that	there	was	a	negative,	but	non-
significant	correlation	between	protein	intake	and	serum	CRP	level	in	cancer	patient	stage	IV,	as	
well	as	fat	intake	and	serum	CRP	level.		
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Introduction 
Cancer is one of the non-communicable diseases 
with high incidence rates and the leading cause of 
death worldwide. Lung cancer is a type of cancer 
with the highest incidence and the leading cause of 
death from cancer in men.1 Based on data from the 
Department of Pulmonology and Respiratory 
Medicine at the Faculty of Medicine University of 
Indonesia – Persahabatan General Hospital, the 
incidence of lung cancer has increased more than 
five-folds in the last 10 years, and most patients 
come at an advanced stage (IIIB/IV).2 Malnutrition 
is a frequent manifestation in cancer patient and 
can negatively affect the outcome of treatments, 
thus a significant contributor to morbidity and 
mortality.3 Studies have demonstrated that 30% to 
87% of cancer patients are diagnosed with 
malnutrition.4 
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Malnutrition in cancer patient is 
multifactorial and can be contributed to several 
factors: local effects of a tumor, the host response 
to the tumor, anticancer therapies, reduced food 
intake due to systemic effects of the disease, local 
tumor effects, psychological effects or adverse 
effects of treatment, and alterations in nutrient 
metabolism and resting energy expenditure (REE).5 
The interactions between cancer cells and normal 
host cells form a tumor microenvironment that 
causes changes in carbohydrate, protein and fat 
metabolism in the host body.6 Metabolic changes 
that occur aim to provide the supply of energy and 
substrate that support the rapid growth of cancer 
cells.7 Nearly a century, Otto H Warburg stated that 
cancer cells take glucose from their surroundings 
more than twice as normal cells and most of the 
glucose is converted into lactate, regardless of the 
presence of oxygen. In cancer patients, in addition 
to the above glycolysis changes, there is also 
insulin resistance.8,9 
  Changes in protein metabolism in cancer 
patients are characterized by decreased protein 
muscle synthesis, increased muscle protein 
catabolism and increased synthesis of acute phase 
proteins, such as C-reactive protein, as a response 
to inflammation.10,11 Insulin resistance leads to 
increased gluconeogenesis pathways and decreases 
protein muscle synthesis. Amino acids, especially 
alanine are broken down for precursors of glucose 
formation.9,12 Changes in lipid metabolism occur 
through increased lipolysis, decreased lipogenesis 
and adipogenesis, as well as increased fat 
oxidation. 
  The progression of lung cancer is 
influenced by the immune system, genetic factors 
and the inflammatory response.13 Increased 
inflammatory response is a component in the 
development of cancer cells that can be 
demonstrated through the increase of acute phase 
proteins (c-reactive protein), so that CRP can be 
relied as one of the parameters for predicting 
cancer cell progression and survival rates in 
patients with various solid cancers.14 
 Research on the intake of carbohydrates, 
proteins and fats with the development of cancer 
cells gives inconsistent results.15-16 Based on the 
above description, a study about correlation 
between carbohydrate, protein and fat intake with 
serum CRP levels as a parameter of cancer cell 
development in lung cancer patients at Dharmais 
Cancer Hospital Jakarta was conducted.  
Methods  
 
This cross-sectional study was conducted in 
Dharmais Cancer Hospital Jakarta from March to 
May 2017. The estimation of minimum sample size 
was calculated using the formula for a correlation 
study17 with a total number of 49 subjects required 
in this study. Subjects were obtained using 
consecutive sampling method. 
All men and women aged above 18 years 
old, diagnosed with lung cancer, stage IIIB–IV, 
currently not receiving any therapy were included 
in this study. Those who agreed to participate in 
this study were asked to sign the informed consent. 
The exclusion criteria were the patients who had 
chronic liver disease, chronic kidney disease, 
diabetes mellitus, and after injury.  
Data were collected through interviews, 
anthropometric measurements and blood sampling. 
Interviews were conducted to determine the 
characteristics of subjects. Macronutrients intake 
was obtained by using a semi-quantitative Food 
Frequency Questionnaire (FFQ). The FFQ was 
used to estimate the macronutrient usual intake in 
the past one month. Anthropometric measurements 
was performed by doing height measurement using 
Microtoise Stature Meter and weight measurement 
using SECA® electrodigital scale. The serum levels 
of CRP were examined using COBAS C311 using 
immunoturbidimetric assay.   
Data was processed using the program 
Statistical Package for Social Sciences (SPSS) for 
Windows version 20. The normality of data 
distributions was analyzed using Shapiro-Wilk test. 
If p<0.05 data were normal distributed and were 
presented as mean ± standar deviation, otherwise 
data were presented as median (minimum-
maximum). The correlation of carbohydrate, 
protein and fat intake with CRP serum were 
analyzed by Spearman rank collection test. 
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Results: 
 
Subjects characteristics 
 
The characteristics of the subjects were 
summarized in Table 1. The mean age of subjects 
was 55.82 + 12.26 years old, most of them were 
men. A total of 67.4% subjects have middle low 
education level and 79.6% have incomes above the 
minimum wage. Cancer histopatology were 95.9% 
non-small cell lung cancer (NSCLC). About 79.6% 
subjects were in stage IV and 57.1% subjects had 
smoking history. Nutritional status assessment used 
body mass index (BMI) parameters based on Asia 
Pasific classification. There were 36.7% 
normoweight subjects and 20.4% underweight 
subjects.  
The median energy intake of the subjects were 
1740.5 (207.5–2527.9) kcal/day, with 53.1% 
subjects showed that energy intake still below 
ESPEN recommendations (30 kcal/kgBW per day). 
The average carbohydate intake were 59.59 + 
8.11%, with 75.5% subject at range of 45–65% 
carbohydrate from total energy. Mean protein 
intake were 63.65 + 25g per day or 15,53 + 3,83% 
of total energy intake. Mean fat intake were 46.57 
+ 22.62 g per day or 24.73 + 6.7% of total energy 
intake.  
Median serum CRP levels were 23.82 mg/L 
(0.30–207.29 mg/L), with 61.2% of subjects having 
serum CRP levels > 10mg/L (Table 2) 
 
 
Table 1 Characteristics of subjects (n=49) 
Variabel  
 
Value 
Age, (year) 55.82 + 12.26* 
Sex, n (%)  
Men  31 (63.3%) 
  Women  18 (36.7%) 
Education, n (%)  
   Low 12 (24.5%) 
   Middle 21 (42.9%) 
   High 16 (32.7%) 
Income, n (%)  
   Below minimum wage  10 (32.7%) 
   Above minimum wage  39 (79.6%) 
Smoking history, n(%)  
Never smoked 21 (42.9%) 
Smoking   28 (57.1%) 
Body mass index, n (%)  
Underweight 10 (20.4%) 
Normoweight  18 (36.7%) 
Overweight   10 (20.4%) 
Obese 1  7 (14.3%) 
Obese 2  4 (8.2%) 
Histopatology, n(%)  
NSCLC 47 (95.9%) 
SCLC 2 (4.1%) 
Stage, n (%)  
III B 10 (20.4%) 
IV 39 (79.6%) 
*Mean + standard deviation ** Median (minimum value - maximum) 
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In this study, we did not find significant correlation 
between carbohydrate, protein and fat intake with 
serum CRP levels. (Table 3) 
Discussions 
 
In this study, the number of male subjects were 
more than women with a ratio of 1.8:1, with 
average age of the subjects of this study was 55.83 
+ 12.62 years. Study by Sutandyo18 conducted at 
the Dharmais Cancer Hospital found similar results 
to the male: female ratio = 3.1:1 and the mean age 
of the patients were 58 years. A total of 57.1% of 
subjects in this study had a history of smoking. 
This is different from the theory that 90% of lung 
cancer incidence is associated with smoking.19 This 
difference may be due to a decrease in the 
prevalence of smoking and the presence of other 
risk factors that can cause lung cancer, such as air 
pollution, prolonged exposure to carcinogenic 
substances.19 Based on data of cancer stage 
distribution, most of research subjects are in stage 
IV. Similar results were also obtained in the 
Sanchez-Lara study.20 This was consistent with the 
prevalence of advanced lung cancer higher than the 
early stages. This condition occured because in the 
early stages, lung cancer often does not show 
symptoms or showing unspecific symptoms, so 
lung cancer was diagnosed when the disease has 
been in an advanced stage.21 
Median total energy intake of the subjects 
in this study were 1740.5 (207.5–2527.9) kcal per 
day or 29.68 + 10.67 kcal/kgBW per day. A total of 
53.1% of subjects showed total energy intake under 
the recommendation of ESPEN. In this study, 
42.9% of subjects were found to have protein 
intake below 1g/kg BW per day with average 
protein intake of 63.65 + 25 g per day or 1.14 g/kg 
BW per day, obtained by dividing total protein 
intake per day per subject with actual body weight. 
Around 57.1% of subjects in this study had low fat 
intake (<25%) with an average fat intake of 24.73 + 
6.7% of total energy intake per day. A few reasons  
that can cause low energy intake in cancer patients 
including the decrease in appetite due to the role of 
pro-inflammatory cytokines in inhibiting the 
orexigenic pathway neuropeptide Y and stimulate 
anorexigenic α-MSH pathway, nausea, satiety and 
chemosensory disorders such as persistent bad taste 
in the mouth, taste distortion, and heightened 
sensitivity to odors  that often occurs in patients 
with advanced cancer.10,22 
Table 2 Serum CRP level 
 
Variabel Value 
Serum CRP level, mg/L 23,82 (0,30 - 207,29)** 
<10 mg/L, n(%) 19 (38,8%) 
>10 mg/L, n(%) 30 (61,2%) 
  
Stage IIIB 14,46 (0,30-141,17)** 
Stage IV 23,82 (1,23 – 207,29)** 
** Median (Minimum – Maksimum)	
Table 3 Correlation between carbohydrate, protein and fat intake with serum CRP levels (n=49)  
Variable Variable Serum CRP  
 
 r value p value  
Carbohydrate intake to total energy (%) 0.015┼ 0.919 
   
Protein intake to total energy (%) -0.165┼	 0.257	
   
Fat intake to total energy (%) 0.003┼ 0.986 
┼ Spearman rank correlation test  
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Serum CRP levels can be relied upon as one of the 
parameters for predicting cancer cell progression in 
patients with various solid cancers.14 This study 
found no correlation between carbohydrate intake 
to total energy (p = 0.919) with serum CRP levels. 
In contrast to studies conducted by Ho et al23 using 
tumor size in mice to assess cancer cell 
progression, there was a significant positive 
correlation between low carbohydrate intake (15% 
of total daily intake) and tumor size (p <0.05). In 
this study, in addition to using tumor size, insulin 
levels and lactate levels are also used as a 
parameter of cancer development. There was 
positive correlation between low carbohydrate diet 
with insulin level and lactate level (p <0.05). The 
difference in outcomes between these two studies 
may be due to low carbohydrate intake, parameters 
used to assess tumor progression, type and stage of 
cancer. Percentage of carbohydrate intake used was 
15%, whereas in this study the average 
carbohydrate intake of the subject was 59.59 + 
8.11%. 
This study has not proved the correlation 
between protein intake to total energy (p=0.257) 
with serum CRP levels. Similarly, a study 
conducted by Lima et al24 found no association 
between protein intake and serum CRP levels 
(p>0.05) in 30 gastrointestinal cancer patients. The 
study by Stobaus et al25 in 285 cancer patients with 
chemotherapy found that a low protein intake 
group (<1 g/kg BW) showed a significant 
difference in mortality (p = 0.024) compared with 
patients from the high protein intake group (>1 g / 
kg BW) and low protein intake is associated with 
fatigue and nausea/vomiting. The results of study 
conducted by Stobaus et al indicate that protein 
intake is good for supporting cancer patients. 
This study has not proved the correlation 
between fat intake to total energy with CRP levels 
(p=0.986). In contrast to a study conducted by 
Fontana et al15 found a significant association 
between fat intake and CRP levels (p<0.027). In the 
study of Fontana et al, a significant relationship 
between fat intake with levels of IGF-1 (p<0.003) 
and leptin levels (p<0.027) was also discovered. 
IGF-1 is mainly regulated by dietary intake to 
stimulate cell proliferation and inhibit cell death, so 
IGF-1 can support tumor development.  
CRP levels are influenced by many factors.26-27 
Some have been controlled such as acute infection, 
chronic illness, acute trauma and pregnancy. But 
there are still those that have not been controlled 
like allergic complication of infection and 
inflammatory diseases. Between macronutrients 
with inflammatory levels in this study using serum 
CRP level as a marker, chronic inflammatory 
biomarkers may be more meaningful when 
associated with intake, since intake is a long-term 
exposure factor.  
In a further stage-based analysis, we did 
found in stage IV cancer patient  there was a 
negative correlation but not significant between 
protein intake to total energy and serum CRP levels 
(r=- 0.293 and p=0.070) as well as fat intake to 
total energy and serum CRP levels (r=-0.060 and 
p=0.717).  From these findings, we further research 
using a larger number of subjects.  
In conclusion, the results of this study can 
not prove that there is a correlation between 
carbohydrate, protein and fat intake with serum 
CRP level in lung cancer stage IIIB–IV. Further 
study regarding the association of macronutrient 
intake with serum CRP level using equally 
distributed subjects according to cancer stage is 
necessary. Early detection on malnutrion and early 
nutrition therapy, education and counseling are 
given to patients and their family to prevent 
malnutrition, which potentially increased morbidity 
and mortality in advanced cancer patient.   
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